期刊簡介 | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱![]() | JOURNAL OF CONTROLLED RELEASE LetPub Score 9.1
50 ratings
Rate
Reputation 9.8 Influence 8.8 Speed 8.7 | ||||||||||||||||
期刊簡稱 | J CONTROL RELEASE | ||||||||||||||||
ISSN | 0168-3659 | ||||||||||||||||
E-ISSN | 1873-4995 | ||||||||||||||||
h-index | 237 | ||||||||||||||||
CiteScore |
| ||||||||||||||||
自引率 (2023-2024) | 3.80%自引率趨勢 | ||||||||||||||||
掲載範囲 |
| ||||||||||||||||
官方網站 | https://www.journals.elsevier.com/journal-of-controlled-release | ||||||||||||||||
在線稿件提交 | https://www.editorialmanager.com/COREL | ||||||||||||||||
開放訪問 | No | ||||||||||||||||
出版商 | Elsevier | ||||||||||||||||
主題領域 | 医学 | ||||||||||||||||
出版國/地區 | NETHERLANDS | ||||||||||||||||
發行頻率 | 月2回刊行 | ||||||||||||||||
創刊年 | 1984 | ||||||||||||||||
每年文章數 | 645每年文章數趨勢 | ||||||||||||||||
黃金OA百分比 | 15.42% | ||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0168-3659%5BISSN%5D | ||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: About 2.6 month(s) 來自Elsevier的數據: Average 6.2 Week(s) | ||||||||||||||||
競爭力 * | 來自作者的數據: 50% | ||||||||||||||||
在線文章發布時間 | 來自Elsevier的數據: Average 6.2 Week(s) | ||||||||||||||||
參考鏈接 |
| ||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
|
首頁 上一頁 1 2 3 4 5 6 下一頁 末頁 (頁 | |
[JOURNAL OF CONTROLLED RELEASE] 的評論 | 撰寫評論 |
作者: 顺利的风铃 領域: 医学 審稿時間: 1.0 month(s) 結果: 拒稿 撰寫評論 |
2025-03-24 15:09:03 評論於 1.21 submit 1.22 editor invited, with editor 2.8 decision in process 2.11 reject ![]() ![]() |
作者: makingnews 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2025-03-13 16:01:39 評論於 Do you no longer need to recommend reviewers for research papers in this journal? ![]() ![]() |
作者: 龙之弄 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2025-02-28 17:01:02 評論於 My editor is still invited. ![]() ![]() |
作者: hhhhhhyy 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2025-02-28 13:48:05 評論於 2.27 决定正在进行中。 ![]() ![]() |
作者: 龙之弄 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2025-02-27 13:52:21 評論於 Brother, my progress is the same as yours. ![]() ![]() |
作者: hhhhhhyy 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2025-02-27 12:52:05 評論於 2.27 Editor Invited ![]() ![]() |
作者: hhhhhhyy 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2025-02-26 16:14:17 評論於 2.26 With Editor ![]() ![]() |
作者: hhhhhhyy 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2025-02-24 16:07:11 評論於 Submitted to Journal on February 24, 2025. ![]() ![]() |
作者: 不二周助 領域: 工程技术 審稿時間: 1.0 month(s) 結果: 修改後接受 撰寫評論 |
2025-02-17 19:41:20 評論於 It took 2.5 months with a total of 4 reviewers, all providing positive feedback and very professional, but the suggestions were not easy to implement. Faced with completing a doctoral degree, finding a job, and writing a thesis, it was fortunate to encounter kind-hearted reviewers. Thank you. ![]() ![]() |
作者: HANJIANGXUE 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2025-02-16 17:00:57 評論於 After "with editor," the decision in process typically lasts for a few days. ![]() ![]() |
作者: Jamie0703 領域: 医学 審稿時間: 2.0 month(s) 結果: 修改後接受 撰寫評論 |
2025-01-28 22:09:50 評論於 10-12, submitted 10-15, with editor 10-18, editor invited 10-22, with editor 10-23, under review 11-03, invited 3 people, 2 accepted and submitted comments 2/2/3, required review complete 11-06, under review, resubmitted 11-18, Revision, invited another reviewer 01-10, revision submitted 01-16, RRC 01-17, under review again 01-22, RRC 01-24, accept ![]() ![]() |
作者: Jamie0703 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2025-01-17 16:58:39 評論於 10-12, submitted 10-15, with editor 10-18, editor invited 10-22, with editor 10-23, under review 11-03, invited 3 people, 2 accepted and submitted opinions 2/2/3, required review complete 11-06, under review, submitted again 11-18, Revision, another invitation sent 01-10, revision submitted 01-16, RRC 01-17, under review again, are they going to send it to new reviewers again? ![]() ![]() |
作者: KateBen 領域: 医药科学 審稿時間: 1.0 month(s) 結果: 待定&不明 撰寫評論 |
2025-01-10 04:59:16 評論於 I am in the same situation. What was the outcome? sent for review or rejected? ![]() ![]() |
作者: LEE 領域: 医学 審稿時間: 2.0 month(s) 結果: 修改後接受 撰寫評論 |
2024-12-23 14:03:53 評論於 10.28 Submitted 10.30 Editor invited 11.02 Under review 11.12 Reviewer1 completed 11.17 Reviewer2 completed 11.19 Major revision 12.03 Revision submitted 12.05 Under review 12.20 Required reviews completed 12.22 Accepted ![]() ![]() |
作者: Jamie0703 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-11-06 23:59:03 評論於 10-18, editor invited 10-22, with editor 10-23, under review 11-03, invited 3 people, 2 accepted and submitted comments 2/2/3, required review complete 11-06, under review, this is under review again. ![]() ![]() |
作者: Jamie0703 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-10-23 20:16:11 評論於 10-18, editor invited 10-22, with editor 10-23, Under Review ![]() ![]() |
作者: John china 領域: 农林科学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-10-21 11:59:16 評論於 Is it under review now? ![]() ![]() |
作者: Jamie0703 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-10-16 00:16:00 評論於 Record the status: 10-12, submitted 10-15, with editor, assigned manuscript number ![]() ![]() |
作者: 缺月疏桐 領域: 医学 審稿時間: 4.0 month(s) 結果: 直接被接受 撰寫評論 |
2024-10-03 09:33:53 評論於 The submission system of Elsevier allows you to track the status of your submission to the Journal of Controlled Release. This email subject for corresponding authors can provide information on the editing process, status of reviewer invitations (how many have been invited, accepted or declined, and how many reviews have been received), all of which will keep you informed about the status of your manuscript. ![]() ![]() |
作者: ajiejiejie 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-09-28 06:04:53 評論於 Around 7.20 submitted; received the results on 9.2, with two minor revisions, returned on 9.10, and it's still in the hands of the editor as of today, 9.28... Not sure if it's because the JCR processing speed has always been slow, or if they are just being cautious and looking for another reviewer. Can any experienced experts provide some insight? Thank you. ![]() ![]() |
作者: 缺月疏桐 領域: 医学 審稿時間: 4.0 month(s) 結果: 直接被接受 撰寫評論 |
2024-09-16 08:45:29 評論於 If it is targeted drug delivery, it requires novelty in chemical synthesis, innovation in responsive release, a high demand for clinical disease treatment, and novelty in disease models. Achieving these aspects will lead to rapid acceptance. Otherwise, like my article, it will be slow and difficult to find reviewers. ![]() ![]() |
作者: 缺月疏桐 領域: 医学 審稿時間: 4.0 month(s) 結果: 直接被接受 撰寫評論 |
2024-09-15 14:35:23 評論於 Record the experience of submitting a paper! The submission to Science Advances was rejected, and the editor recommended submitting to JCR. On May 12, 2024, the paper was submitted to the journal, with the editor assigned on May 20. On May 28, the paper was under review, with 2 reviews completed. 3 review invitations were accepted and 3+ review invitations were sent. This status lasted for one month before the review was completed on June 20. A revision was submitted on July 20 and reviews were completed on August 10, with 1 review invitation accepted and 2 review invitations sent (PS During the major revision, there were 3 reviewers, 1 acceptance, and 2 modifications). On September 14, there was a reminder for some new reviews for COREL-D-24-01810R1 in "Peer review status", and I recommended additional reviewers. The paper was accepted on September 15. ![]() ![]() |
作者: 缺月疏桐 領域: 医学 審稿時間: 4.0 month(s) 結果: 直接被接受 撰寫評論 |
2024-09-15 14:35:03 評論於 This is the first time submitting an article to JCR, which is said to be the top journal in pharmacy, so I have high expectations. ![]() ![]() |
作者: Cassatt 領域: 医学 審稿時間: 4.0 month(s) 結果: 修改後接受 撰寫評論 |
2024-09-05 09:49:18 評論於 4.17 submit 4.22 editor invited 4.23 under review 5.2 under review 6.2 under review 6.12 under review 6.22 revise 9.3 accept ![]() ![]() |
作者: plain river 領域: 医学 審稿時間: 3.0 month(s) 結果: 修改後接受 撰寫評論 |
2024-08-24 11:30:53 評論於 Submitted in March, accepted in July, featured article! ![]() ![]() |
首頁 上一頁 1 2 3 4 5 6 下一頁 末頁 (頁 |
Contact us